Interleukin Genetics Revenue and Competitors
Estimated Revenue & Valuation
- Interleukin Genetics's estimated annual revenue is currently $4.5M per year.
- Interleukin Genetics's estimated revenue per employee is $155,000
Employee Data
- Interleukin Genetics has 29 Employees.
- Interleukin Genetics grew their employee count by 4% last year.
Interleukin Genetics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Interleukin Genetics?
Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets proprietary genetic tests for chronic inflammatory diseases and health-related conditions, with significant expertise in metabolism and inflammation. The products empower individuals and their healthcare providers to manage prevention and treatment of chronic diseases through genetics-based insights and actionable guidance. Interleukin Genetics' lead products include its proprietary ILUSTRA™ Inflammation Management Program and its Inherent Health® line of genetic tests. Key Products: • ILUSTRA™ Inflammation Management Program – Uses a simple, oral cheek swab sample to accurately measure variations in the genes for Interleukin-1 (IL-1), a key regulator of inflammation, which can lead to chronic disease, including severe periodontitis. ILUSTRA™ is supported by an integrated program that provides targeted dental education and patient engagement to transform the management of inflammation and promote wellness. • Inherent Health® Line of Genetic Tests – A full suite of affordable, easy-to-use and meaningful genetic tests in weight management and nutritional needs.
keywords:N/A
N/A
Total Funding
29
Number of Employees
$4.5M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Interleukin Genetics News
... Illumina, Thermo Fisher Scientific, Bio-Rad, Roche, Lonza, INVITAE, Genetic Technologies, Interleukin Genetics, Eastern Biotech.
Prior human genetic studies identified interleukin 6 receptor (IL-6R) as a putative causal factor for CAD (8, 9), bolstered by the CANTOS...
The UAB researchers developed mice that have a reporter gene in IL-22, so they could tell which cells produced IL-22.
Other Companies in Waltham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $13.7M | 29 | -22% | N/A |
#2 | $4.5M | 29 | -24% | N/A |
#3 | $4.5M | 29 | 7% | N/A |
#4 | $3.9M | 30 | -36% | $10.8M |
#5 | $3.6M | 30 | 7% | N/A |